Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design Annelienke M. van Hulst, Emma J. Verwaaijen, Marta Fiocco, Saskia M.F. Pluijm, Martha A. Grootenhuis, Rob Pieters, Erica L.T. van den Akker, Marry M. van den Heuvel-Eibrink BioMed Central Pediatrics. 2021 Sep;21(1):427-435
RkJQdWJsaXNoZXIy MTk4NDMw